TNO Leads the Charge in Digital Health Innovations
The Hague, Friday, 9 May 2025.
Netherlands-based TNO is pioneering patient-centric digital health solutions, emphasizing personalized prevention to drive sustainable health advancements and societal prosperity.
Innovative Digital Health Solutions
At the forefront of TNO’s digital health initiatives is the groundbreaking Psycat system, an online assessment tool designed for early detection of psychosocial issues in children aged 2-4 and 7-11 years. This adaptive questionnaire system represents a significant advancement in preventive mental health care, utilizing smart algorithms to present only the most relevant questions for each case [1]. The organization’s commitment to health innovation is further demonstrated through their upcoming AI and healthcare integration showcase at the Appl.AI Splash event, scheduled for April 22, 2025, where experts will present breakthrough developments in trustworthy AI decision support systems for healthcare [4].
Technology Integration and Research Infrastructure
TNO’s commitment to advancing healthcare technology is evidenced by the recent launch of the Holst Centre Photonics Lab on May 7, 2025. This state-of-the-art facility is specifically designed to accelerate developments in non-invasive medical diagnostics and other healthcare applications [3]. The lab represents a significant step forward in bringing integrated photonics innovations from laboratory concepts to practical medical applications, particularly in the realm of diagnostic technologies [6].
Strategic Shifts and Future Focus
While maintaining its core focus on digital health innovations, TNO is strategically realigning its priorities in 2025. This repositioning includes a reduced emphasis on certain areas such as food processing solutions [5], allowing for increased focus on digital health technologies and personalized prevention strategies. The organization continues to strengthen its position in healthcare innovation through strategic partnerships and infrastructure development, as demonstrated by the €15 million European investment in photonics technologies that will directly benefit healthcare applications [7].